Home
Conditions
Tumor Virus Infections

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies

Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Completed

Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine

NCT00316693

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: GSK Investigational Site Kagoshima, Japan

GSK Investigational Site Tokyo, Japan

GSK Investigational Site Tokyo, Japan

GSK Investigational Site

View Trial Details

Completed

Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age

NCT00492544

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations: GSK Investigational Site Saitama, Japan

GSK Investigational Site Saitama, Japan

GSK Investigational Site Tokyo, Japan

GSK Investigational Site Tokyo, Japan

View Trial Details

Completed

Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer

NCT00134017

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +66 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma

NCT00416312

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +39 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)

NCT00090285

Conditions: Communicable Diseases, Condylomata Acuminata, DNA Virus Infections, +16 more
Locations: Not specified

View Trial Details

Completed

Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18

NCT00122681

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Fountain Valley, California, United States

GSK Investigational Site San Diego, California, United States

GSK Investigational Site San Francisco, California, United States

View all 138 locations

View Trial Details

Completed

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

NCT00002461

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: Albert Einstein Comprehensive Cancer Center The Bronx, New York, United States

View Trial Details

Completed

Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects

NCT00996125

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: GSK Investigational Site Taizhou, Jiangsu, China

View Trial Details

Completed

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

NCT00578227

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations: GSK Investigational Site Surrey, British Columbia, Canada

GSK Investigational Site Brampton, Ontario, Canada

GSK Investigational Site Greater Sudbury, Ontario, Canada

GSK Investigational Site Newmarket, Ontario, Canada

View all 21 locations

View Trial Details

Completed

Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects

NCT00652938

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations: GSK Investigational Site Nijmegen, Netherlands

GSK Investigational Site Rotterdam, Netherlands

GSK Investigational Site Linköping, Sweden

GSK Investigational Site Luleå, Sweden

View Trial Details

Tumor Virus Infections

Tumor Virus Infections trial results

Related conditions